Antidepressant Prescriptions Surge Among Young People, Fueled by Social Media Trends

Antidepressant use is rapidly increasing among both adults and children, with a growing trend of openly discussing and even promoting these medications as a lifestyle choice, particularly on social media platforms.

Approximately 9 million adults and 500,000 children received antidepressant prescriptions last year, according to recent data. Notably, online engagement with content related to antidepressants has exploded; user shares for videos tagged #ssri have nearly quadrupled between 2022 and 2025, and #antidepressants has amassed over 1.3 billion views on TikTok. This rise in visibility is accompanied by influencers, some with financial ties to pharmaceutical companies, portraying antidepressants as a form of self-care and empowerment. This trend raises concerns about potential over-prescription and a misunderstanding of the medications’ long-term effects.

The normalization of antidepressant use occurs alongside a broader shift in wellness culture among Generation Z, who increasingly prioritize practices like pilates, juice cleanses, and supplements over traditional indulgences like alcohol and smoking. Despite this focus on holistic well-being, the appeal of a pharmaceutical solution to life’s challenges remains strong, potentially driven by social media’s emphasis on optimizing every aspect of life. Experts at the National Institute of Mental Health caution that while antidepressants can be beneficial for some, they are not without potential side effects and withdrawal challenges.

While some individuals report positive experiences with antidepressants, content creators often do not fully disclose the potential downsides, including adverse reactions and dependence. The increasing reliance on medication for mental health, rather than addressing underlying issues, could have long-term consequences for individual well-being and societal approaches to mental healthcare. Health officials are monitoring the situation closely and are expected to release further guidance on responsible prescribing practices in the coming months.